(OPRX) OPTIMIZERx - Ratings and Ratios

OptimizeRx Corporation (NASDAQ: OPRX) is a digital health technology company that connects life sciences organizations, healthcare providers, and patients through a suite of tech-enabled marketing solutions. Its core platform leverages AI to generate dynamic audiences and activate real-time, data-driven campaigns. This platform allows clients to execute both traditional and dynamic marketing strategies, optimizing audience engagement during critical moments in patient care. By integrating with its proprietary digital point-of-care network, the company enhances the value of treatment information for healthcare professionals and patients, aligning marketing efforts with clinical care events. Founded in 2006, OptimizeRx operates from its headquarters in Waltham, Massachusetts.

Technical Analysis: OPRX is currently trading at $5.28, below its 20-day SMA of $5.69 and 50-day SMA of $5.42, but above its 200-day SMA of $7.56. The stock has shown recent volatility, with an ATR of 0.42, and averages 120,345 shares traded over the past 20 days.

Fundamental Analysis: The company has a market cap of $106.47 million, with a forward P/E of 16.29 and a price-to-book ratio of 1.00. Its price-to-sales ratio stands at 1.21, and the return on equity is -21.12%, indicating current profitability challenges.

3-Month Forecast: Based on the convergence of technical and fundamental data, OPRX is expected to experience modest volatility with potential upside driven by its forward P/E valuation. Support levels may form near $5.00, while resistance could emerge at $6.50. The stocks performance will likely hinge on its ability to demonstrate revenue growth and improve profitability metrics.